CAMICIOTTOLI, GIANNA
 Distribuzione geografica
Continente #
NA - Nord America 7.860
EU - Europa 6.061
AS - Asia 4.005
SA - Sud America 402
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 117
OC - Oceania 97
Totale 18.662
Nazione #
US - Stati Uniti d'America 7.700
RU - Federazione Russa 1.851
IT - Italia 1.678
SG - Singapore 1.097
CN - Cina 909
PL - Polonia 753
HK - Hong Kong 608
IE - Irlanda 504
VN - Vietnam 463
SE - Svezia 420
KR - Corea 348
BR - Brasile 325
FI - Finlandia 209
FR - Francia 177
DE - Germania 168
JO - Giordania 140
IN - India 109
CA - Canada 97
AU - Australia 96
GB - Regno Unito 95
JP - Giappone 90
UA - Ucraina 79
BD - Bangladesh 67
CI - Costa d'Avorio 41
ID - Indonesia 37
TR - Turchia 32
CH - Svizzera 27
AR - Argentina 26
IQ - Iraq 25
MX - Messico 23
NG - Nigeria 21
NL - Olanda 21
BE - Belgio 17
PK - Pakistan 14
EC - Ecuador 13
RO - Romania 13
ZA - Sudafrica 13
CL - Cile 10
PH - Filippine 10
AE - Emirati Arabi Uniti 8
ES - Italia 8
JM - Giamaica 8
UZ - Uzbekistan 8
VE - Venezuela 8
KE - Kenya 7
MA - Marocco 7
CO - Colombia 6
EG - Egitto 6
PY - Paraguay 6
SA - Arabia Saudita 6
AL - Albania 5
BJ - Benin 5
CR - Costa Rica 5
EU - Europa 5
HN - Honduras 5
PE - Perù 5
PR - Porto Rico 5
RS - Serbia 5
SI - Slovenia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LT - Lituania 4
MY - Malesia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
KW - Kuwait 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AT - Austria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GT - Guatemala 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LV - Lettonia 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
Totale 18.538
Città #
Santa Clara 1.877
Warsaw 748
Singapore 745
Ashburn 580
Dublin 504
Hong Kong 485
Chandler 478
Fairfield 470
Milan 394
San Jose 388
Seoul 344
Beijing 221
Woodbridge 199
The Dalles 186
Cambridge 177
Council Bluffs 167
Seattle 164
Wilmington 160
Rome 153
Houston 151
Hefei 149
Buffalo 142
Hanoi 138
Ho Chi Minh City 134
Princeton 133
Jacksonville 131
Florence 125
Lauterbourg 124
Los Angeles 117
Ann Arbor 115
Melbourne 91
Tokyo 87
Moscow 85
Boston 82
Medford 78
Boardman 77
New York 74
Helsinki 71
Lawrence 63
Altamura 57
Mumbai 57
Munich 50
Kent 47
Shanghai 46
Abidjan 41
Dallas 35
Norwalk 35
Redondo Beach 35
San Diego 34
Turin 28
Haiphong 27
Naples 27
Falls Church 24
Bern 23
Jakarta 23
São Paulo 23
Frankfurt am Main 22
Orem 22
Figino 21
Hillsboro 21
London 19
Toronto 19
Yubileyny 19
Abuja 18
Bologna 18
Da Nang 18
Chicago 17
Izmir 17
Turku 17
Brussels 16
Bari 15
Brooklyn 15
Chennai 15
Clifton 15
Palermo 15
Dong Ket 14
Paris 14
Atlanta 13
San Francisco 13
Guangzhou 12
Bengaluru 11
Genoa 11
Messina 11
Baghdad 10
Catania 10
Vicenza 10
West Jordan 10
Andover 9
Dearborn 9
Miano 9
Mountain View 9
Padua 9
Phoenix 9
Reggio Emilia 9
Rio de Janeiro 9
Stockholm 9
Verona 9
Washington 9
Amsterdam 8
Johannesburg 8
Totale 11.812
Nome #
COPD: maximization of bronchodilation 393
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD 329
Is intrathoracic tracheal collapsibility correlated to clinical phenotypes and sex in patients with COPD? 327
Immunoglobulin replacement therapy for yellow nail syndrome 310
Interstitial lung disease in systemic sclerosis: Where do we stand? 285
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease 271
Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. 261
Non-contact detection of breathing using a microwave sensor 249
Discussione di casi clinici: Il caso di Pneumologia 234
Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes. 219
Chronic Obstructive Pulmonary Disease: Pulmonary Function and CT Lung Attenuation Do Not Show Linear Correlation. Paoletti M, Cestelli L, 217
CHANGES IN TRANSCUTANEOUS OXYGEN PARTIAL PRESSURE AS AN INDEX OF RESPONSE TO INHALED METHACHOLINE IN ASTHMATIC PATIENTS. 215
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. 209
Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. 205
Different respiratory behaviors disclosed by induced bronchoconstriction in mild asthma patients. 199
BODE_index, modified BODE-index and ADO score in Chronic Obstructive Pulmonary Disease: relationship with COPD phenotypes and CT lung density changes 198
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 194
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. 193
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 193
Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease 189
Glottis Closure Influences Tracheal Size Changes in Inspiratory and Expiratory CT in Patients with COPD. 188
Whole-lung volume and density in spirometrically-gated inspiratory and expiratory CT in systemic sclerosis: correlation with static volumes at pulmonary function tests 183
Induced sputum in systemic sclerosis interstitial lung disease: Comparison to healthy controls and bronchoalveolar lavage 174
Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report 171
A prospective study on respiratory function in children affected with Systemic Lupus Erithematosus 170
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 170
ENFISEMA POLMONARE 168
Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial 167
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 165
Agreement between two methods fr assessing bioequivalence of inhaled salbutamol. 163
Comparison of spirometric-gated and -ungated HRCT in COPD. 162
Airway response to fenoterol hydrobromide and oxitropium bromide alone or in sequence in stable COPD patients 161
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life 158
Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer 155
Fog-induced respiratory responses are attenuated by nedocromil sodium in humans 155
Classification of COPD patients by using a standardised diagnostic questionnaire 155
Low agreement of visual rating for detailed quantification of pulmonary emphysema in whole lung CT 154
Thin-section and low-dose volumetric computed tomographic densitometry of the lung in systemic sclerosis. 152
Chronic effort dyspnea explained by lung function tests and by HRCT and CRX radiografic patterns in COPD: a post-hoc analysis in 51 patients 149
Whole-lung densitometry versus visual assessment of emphysema 149
Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients. 148
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients 147
Studio prospettico della funzione respiratoria in bambini affetti da Lupus Eritematoso Sistemico 147
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 147
Clinical Identification of CT-Determined COPD Phenotypes 146
Asthma remission one, none and one-hundred thousand: the relevance of the patient’s view 145
“Adrenaline junkie”: a case report of repeated use of epinephrine 143
Classification of COPD patients by using standardised diagnostic procedures 141
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT 141
[Lymphangioleiomyomatosis. The computed tomographic aspects in an early case]. 140
Chest x-ray findings in different Phenotypes, GOLD stages and BODE scores of Chronic Obstructive Pulmonary Disease 138
EFFECT ON LUNG FUNCTION OF METHOTREXATE AND NON-STEROID ANTI-INFLAMMATORY DRUGS IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS 137
Classificazione diagnostica standardizzata dei pazienti con BPCO 135
Omalizumab improves asthma-related quality of lifein allergic asthmatic patients 134
Clinical utility of noninvasive methods in the evaluation of scleroderma lung in pediatric age 132
Effetti della terapia con metotrexate (MTX) e degli antiinfiammatori non steroidei sulla funzione polmonare e sulla capacità di diffusione in bambini affetti da artrite reumatoide giovanile 132
Determination of ai rway resistance (Raw) and pulmonary flow resistance (RL) during methacoline challenge in children 131
Expiratory quantitative HRCT parameters reflect better than inspiratory parameters disfunction in COPD. 129
Prediction by pulmonary function tests of HRCT lung density parameters in COPD 129
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? 129
Modificazioni sequenziali cardio respiratorie in corso di danno lesionale sperimentale da acido oleico 129
PULMONARY LYMPHANGIOLEIOMYOMATOSIS. A CASE REPORT AND REVIEW 128
Clinical Identification of CT-Determined COPD Phenotypes 128
In vitro validation and preliminary clinical application of a software for the computation of lung nodules volume in the Italung-CT trial 128
Cardiovascular comorbidities prevail in the early stages of COPD irrespective of predominant airway or emphysema phenotype 128
Phenotypes of chronic obstructive pulmonary disease 127
Comparison of dose-response slopes obtained by simultaneous assessment of changes in FEV1 and transcutaneous oxygen partial pressure during methacholine challenges in asthmatic patients. 127
What does phenotype mean in the field of COPD 126
Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life 126
Lung densitometry: Why, how and when 125
Omalizumab improves asthma-related quality of life in allergic asthmatic patient 124
Malattie polmonari parenchimali diffuse 123
Changes in the pattern of breathing and dyspnea sensation during methacholine-induced bronchoconstriction in asthmatic patiens 123
PULMONARY FUNCTION IN CHILDREN AFFECTED BY JUVENILE SPONDYLOARTHROPATHY 122
Valutazione dei parametri quantitativi derivati dalla tomografia computerizzata ad alta risoluzione (HRCT) in pazienti BPCO: confronto con i tests di funzionalità respiratoria 122
Densitometria vs visual score nella valutazione dell’enfisema polmonare con TC 122
High resolution and spirometric synchronization computerized tomography in chronic obstructive bronchopneumopathy 122
L’edema Polmonare 118
Impiego di un dispositivo di interruzione del flusso delle vie aeree per la misura delle resistenze respiratorie (RL) 118
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 117
Severe asthma: One disease and multiple definitions 117
Valutazione densitometrica polmonare nella sclerosi sistemica. Riproducibilità e correlazioni clinico-funzionali 116
Identification of a predominant clinical COPD phenotype in clinical practice 114
Spirometrically gated high-resolution CT findings in COPD: lung attenuation vs lung function and dyspnea severity. 112
Mepolizumab Effectiveness and Allergic Status in Real Life 110
Italian real life experience of Omalizumab 110
High resolution computed tomography quantitative parameters in COPD. Comparison with pulmonary function tests 110
Thin section CT and low dose volumetric CT densitometry of the lung in Systemic Sclerosis 108
Lung involvement in Juvenile dermatomyositis (JDM): Muscle strenght and pulmonary function tests in children with JDM 106
Different cell compositions in induced sputum samples from patients with Systemic Sclerosis: relationship with antibodies and interstitial lung fibrosis 102
Defining the contribution of emphysema and chronic bronchitis in COPD patients 101
The Severe Asthma Network in Italy: Findings and Perspectives 101
Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease: a comparison of 3 techniques. 95
Prediction of Pulmonary Function in COPD on the Basis of CT Measurements of Bronchial Wall Thickness 95
Studio prospettico sulla funzionalità respiratoria e determinazione della forza muscolare in pazienti di età pediatrica affetti da dermatomiosite 95
Interessamento polmonare in pazienti asintomatici con artrite reumatoide giovanile (ARG), HLAB27 positivi. Studio prospettico della funzionalità respiratoria 95
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 94
Diagnostica per immagini della BPCO 94
Clinical Phenotypes in patients with COPD 93
Whole-lung densitometry vs visual assessment of emphysema 91
Totale 15.472
Categoria #
all - tutte 51.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022731 0 112 23 55 20 12 14 55 22 20 129 269
2022/20232.033 216 235 71 147 179 390 282 104 295 27 57 30
2023/2024811 58 134 170 59 66 84 19 93 8 35 56 29
2024/20255.249 174 520 406 720 1.668 669 65 312 253 94 185 183
2025/20266.051 641 815 490 301 514 209 932 252 417 338 213 929
2026/2027412 250 162 0 0 0 0 0 0 0 0 0 0
Totale 18.662